Clinical trial
Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events…
NCT00161369 · University of Shizuoka, Other · Completed
Key facts
| NCT number | NCT00161369 |
|---|---|
| Title | Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis Patients |
| Official title | Contribution of Homocysteine and Asymmetric Dimethylarginine to Atherosclerosis and Cardiovascular Events in Maintenance Hemodialysis Patients |
| Lead sponsor | University of Shizuoka, Other |
| Collaborators | Maruyama Memorial General Hospital Hamamatsu University |
| Status | Completed |
| Study type | Observational |
| Conditions | Chronic Renal Failure, Hemodialysis, Atherosclerosis |
| Enrollment | 200 |
| Start date | Apr 1, 2000 |
| Completion | Mar 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Oct 21, 2005 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: